Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation.
Atrial fibrillation is the most common sustained arrhythmia encountered in clinical practice. Its prevalence is rising due to an increasing elderly population and the improvement in management of life-threatening diseases such as myocardial infarction and heart failure. Over the past few years effective non-pharmacological treatments, new antiarrhythmics drugs, and anticoagulants have been introduced. Regardless of rate-control or rhythm control strategy, adequate stroke prevention still remains a cornerstone in the treatment of this arrhythmia. This review aims to illustrate the main practical issues in the management of atrial fibrillation, focusing on patients with recent-onset and hemodynamically stable atrial fibrillation.
Emergency Department, Ospedale Civile Santa Maria della Scaletta, via Montericco 4, 40026, Imola (Bo), Italy. andrea.tampieri@libero.it
Andrea
A
Tampieri
Anna Maria
AM
Rusconi
Tiziano
T
Lenzi
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy*; D017115:Catheter Ablation; D004554:Electric Countershock / Q000379:methods*; D004562:Electrocardiography; D006439:Hemodynamics; D006801:Humans; D015995:Prevalence; D013923:Thromboembolism / Q000517:prevention & control
D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants